Hiv-1 Env Glycoprotein Variant


The full document isn't yet available to us from the patent office.


The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jan 1, 2014
  • Application: Jun 26, 2013
    EP EP 13003261 A
  • Priority: Jun 27, 2012
    US US 201261664990 P

Download Citation

Sign in to the Lens